SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 90,815,000 | $90,802,681 | 5.68% |
| PIPER SANDLER & CO. | 6,695,000 | $6,694,063 | 4.58% |
| Opti Capital Management, LP | 46,902,000 | $46,902,000 | 3.79% |
| Monashee Investment Management LLC | 9,000,000 | $8,975,160 | 2.48% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $97,297,084 | 1.93% |
| DeepCurrents Investment Group LLC | 41,092,000 | $40,966,177 | 1.60% |
| Sonora Investment Management Group, LLC | 9,395,000 | $9,387,582 | 0.82% |
| Penn Mutual Asset Management | 675,000 | $677,018 | 0.64% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,540,000 | $19,586,199 | 0.22% |
| BRAIDWELL LP | 6,500,000 | $6,515,368 | 0.22% |